openPR Logo
Press release

Deadline in Lawsuit for Investors in TG Therapeutics, Inc. (NASDAQ: TGTX) on September 16, 2022 coming up

09-12-2022 11:48 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on September 16, 2022 in the lawsuit for certain investors in TG Therapeutics, Inc. (NASDAQ: TGTX).

A Deadline is coming up on September 16, 2022 in the lawsuit for certain investors in TG Therapeutics, Inc. (NASDAQ: TGTX).

A deadline is coming up on September 16, 2022 in the lawsuit filed for certain investors of TG Therapeutics, Inc. (NASDAQ: TGTX) over alleged securities laws violations by TG Therapeutics, Inc.

Investors who purchased shares of TG Therapeutics, Inc. (NASDAQ: TGTX) have certain options and there are strict and short deadlines running. Deadline: September 16, 2022. TG Therapeutics, Inc. (NASDAQ: TGTX) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of TG Therapeutics, Inc. (NASDAQ: TGTX) common shares between January 15, 2020 and May 31, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between January 15, 2020 and May 31, 2022, the Defendants made false and/or misleading statements and/or failed to disclose that clinical trials revealed significant concerns related to the benefit-risk ratio and overall survival data of Ublituximab and Umbralisib, that accordingly, it was unlikely that the Company would be able to obtain FDA approval of the Umbralisib MZL/FL NDA, the U2 BLA, the U2 sNDA, or the Ublituximab RMS BLA in their current forms, that as a result, the Company had significantly overstated Ublituximab and Umbralisib's clinical and/or commercial prospects, and that therefore, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of TG Therapeutics, Inc. (NASDAQ: TGTX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline in Lawsuit for Investors in TG Therapeutics, Inc. (NASDAQ: TGTX) on September 16, 2022 coming up here

News-ID: 2732031 • Views: 300

More Releases from Shareholders Foundation

Investigation announced for Investors who lost Money with their shares in Roblox …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Roblox Corporation. Investors who purchased shares of Roblox Corporation (NYSE: RBLX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Roblox directors breached their fiduciary duties and caused damage to the company and its shareholders. San Mateo, CA based Roblox Corporation develops
Investigation announced for Investors in Waterdrop Inc. (NYSE: WDH) over possibl …
An investigation was announced over potential securities laws violations by Waterdrop Inc. in connection with certain financial statements. Investors who purchased shares of Waterdrop Inc. (NYSE: WDH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Waterdrop Inc. (NYSE: WDH regarding its business, its prospects and its operations were materially
Sinovac Biotech Ltd. (formerly NASDAQ: SVA) Investor Notice: Deadline in Lawsuit …
A deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) over alleged securities laws violations by Sinovac Biotech Ltd. Investors who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) have certain options and there are strict and short deadlines running. Deadline: October 17, 2022. Sinovac Biotech Ltd. (formerly NASDAQ: SVA) stockholders should contact the Shareholders Foundation at
Investigation announced for Investors in Anaplan, Inc. (NYSE: PLAN) over potenti …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Anaplan, Inc. Investors who are current long term investors in Anaplan, Inc. (NYSE: PLAN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: PLAN stocks follows a lawsuit filed against Anaplan, Inc. over

All 5 Releases